AVATR enters the NHS

Inavya has won a competition to research and develop its AVATR technology to benefit the National Health Service.

The Office for Life Sciences and Innovate UK, as part of UK Research and Innovation, are investing up to £1.5 million in innovation projects such as AVATR. The competition is aimed at SMEs that have developed and manufactured innovative healthtech, including medical devices, diagnostics and regulated digital healthcare products.

Dr Michael Wilkinson, CEO and Founder of Inavya, said “After several years of developing AVATR technology with clinicians in Singapore and São Paulo, we are delighted to be entering the NHS healthcare ecosystem, where we aim to deliver significant benefits to citizens and the NHS with AVATR, a CE marked medical device.”